Re: MD&A and Financials Sept 16, 2019
in response to
by
posted on
Sep 17, 2019 08:16AM
I was immediately intrigued with the Third Eye repayment date of 9/27, and the expected TLD date of 9/30, one business day later. Obvious strategy/tactic Just not sure why?
I "get" that Third Eye may want to be repaid prior to any further risk. And that even though TLD may not be officially released by 9/30, it surely will be known. So, it leaves the question of "WHOM" exactly RVX may be allowed to disclose TLD to prior to general release to the public? - not sure about fiduciary obligations/responsibilities in that area?
My assumption would be that if Third Eye is pressing, if possible, you go to your heavy hitters like Hepalink, Ken Dart, etc, and ask for the dough ... it is in THEIR own best interests to cough up some more dough, "if" Third Eye is playing tough, or conservatively. I am wondering though if RVX can share sensitive data to key "partners" that are also investors, prior to releasing to the market and the general book of investors like me? ... different "classes" of investors? Some may be categorized finance partners also, rather than or in addition to "investors" also, maybe?
If TLD is positive, cash will not be a problem, easy deals to make (for a price), given the upside if it is known to be positive data? ... and they will certainly know the TLD outcomes by 9/27, in order to deliver TLD on or about 9/30.
I don't think this is a worry in reality, unless the data is bad ... then, there are other bigger problems, in THAT case.